Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial

Hong Ren,Xiao Li,Zhaohui Ni,Jian-Ying Niu,Bin Cao,Jie Xu,Hong Cheng,Xiao-wen Tu,Ai-Min Ren,Ying Hu,Changying Xing,Yinghong Liu,Yan-Feng Li,Jun Cen,Rong Zhou,Xu-Dong Xu,Xiao-Hui Qiu,Nan Chen

Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial

2017

Hong Ren
Xiao Li
Zhaohui Ni
Jian-Ying Niu
Bin Cao
Jie Xu
Hong Cheng
Xiao-wen Tu
Ai-Min Ren
Ying Hu
Changying Xing
Yinghong Liu
Yan-Feng Li
Jun Cen
Rong Zhou
Xu-Dong Xu
Xiao-Hui Qiu
Nan Chen

Objective To compare the efficacy and safety of short-course intravenous levofloxacin (LVFX) 750 mg with a conventional intravenous/oral regimen of LVFX 500 mg in patients from China with complicated urinary tract infections (cUTIs) and acute pyelonephritis (APN).

Keywords:

Clinical trial
Cutis
Regimen
Levofloxacin
Short course
Diabetes mellitus
Urinary system
Anesthesia
Medicine
Levofloxacin 500 MG
open label
Nephrology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations